WTB RSS
01-27-2012, 04:04 PM
Swiss pharmaceutical giant Novartis ( NVS ) reported earnings per share of $1.23 for the fourth quarter of 2011, marginally beating the Zacks Consensus Estimate of $1.22. http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/0/di (http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/0/da)
http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/1/di (http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/4oRPf2uxXBA
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/4oRPf2uxXBA/nvs-beats-by-a-penny-view-guarded-analyst-blog.aspx)
http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/1/di (http://feedads.g.doubleclick.net/~a/uikIhbB3kEfq2wBc4QB4XJBaKdc/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/4oRPf2uxXBA
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/4oRPf2uxXBA/nvs-beats-by-a-penny-view-guarded-analyst-blog.aspx)